Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Integrin alpha-V beta-5 (αVβ5) is a heterodimeric transmembrane receptor composed of alpha V (ITGAV) and beta 5 (ITGB5) subunits. It binds to ligands containing an RGD (Arg-Gly-Asp) motif, notably vitronectin. αVβ5 mediates cell adhesion, migration, and signal transduction and plays roles in retinal pigment epithelium function, cancer, and viral infection. It is located primarily on the plasma membrane.
RGD sequence recognition and binding to extracellular matrix proteins; Integrin activation and downstream signaling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Integrin alpha-V beta-5 (αVβ5).